- Q4 2023 Iovance Biotherapeutics Inc Earnings Call TranscriptFeb 28, 2024$17.43 (-0.23%)Earnings
- Iovance Biotherapeutics Inc FDA Approval Call TranscriptFeb 16, 2024
- Q3 2023 Iovance Biotherapeutics Inc Earnings Call TranscriptNov 07, 2023$4.32Earnings
- Q2 2023 Iovance Biotherapeutics Inc Earnings Call TranscriptAug 08, 2023$7.14 (+1.28%)Earnings
- Iovance Biotherapeutics Inc Melanoma Treatment Landscape TranscriptJun 26, 2023
- Iovance Biotherapeutics Inc at Jefferies Healthcare Conference TranscriptJun 09, 2023
- Q1 2023 Iovance Biotherapeutics Inc Earnings Call TranscriptMay 09, 2023$7.36 (+3.95%)Earnings
- Iovance Biotherapeutics Inc at Chardan Genetic Medicines & Cell Therapy Manufacturing Summit (Virtual) TranscriptApr 24, 2023
- Iovance Biotherapeutics Inc at Barclays Global Healthcare Conference TranscriptMar 15, 2023
- Iovance Biotherapeutics Inc at Oppenheimer Healthcare Conference (Virtual) TranscriptMar 14, 2023
- Krystal Biotech Inc, Affyimmune Therapeutics Inc, Rocket Pharmaceuticals Inc and Iovance Biotherapeutics Inc at Endpoints Webinar on Moving CGTx Clinical Development- Panel TranscriptMar 02, 2023
- Q4 2022 Iovance Biotherapeutics Inc Earnings Call TranscriptFeb 28, 2023$7.29 (+1.67%)Earnings
- Iovance Biotherapeutics Inc Corporate Call TranscriptJan 23, 2023
- Iovance Biotherapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 11, 2023
- Iovance Biotherapeutics Inc Corporate Call TranscriptNov 18, 2022
- Iovance Biotherapeutics Inc to Discuss the Pooled Analysis of Cohorts 2 and 4 of the C-144-01 Study TranscriptNov 10, 2022
- Q3 2022 Iovance Biotherapeutics Inc Earnings Call TranscriptNov 03, 2022$8.53 (-4.16%)Earnings
- Q2 2022 Iovance Biotherapeutics Inc Earnings Call TranscriptAug 04, 2022$12.54 (+4.15%)Earnings
- Iovance Biotherapeutics Inc at Goldman Sachs Global Healthcare Conference TranscriptJun 15, 2022
- Iovance Biotherapeutics Inc at JMP Securities Life Sciences Conference TranscriptJun 15, 2022
- Iovance Biotherapeutics Inc at Jefferies Healthcare Conference TranscriptJun 09, 2022
- Iovance Biotherapeutics Inc to Discuss Updates for the C-144-01 Clinical Study TranscriptMay 26, 2022
- Q1 2022 Iovance Biotherapeutics Inc Earnings Call TranscriptMay 05, 2022$14.83 (-10.12%)Earnings
- Iovance Biotherapeutics Inc at Chardan Genetic Medicines and Cell Therapy Manufacturing Summit (Virtual) TranscriptApr 26, 2022
- Iovance Biotherapeutics Inc to Provide Melanoma Regulatory and Clinical Updates Call TranscriptApr 06, 2022
- Iovance Biotherapeutics Inc at Barclays Global Healthcare Conference TranscriptMar 17, 2022
- Iovance Biotherapeutics Inc at Oppenheimer Healthcare Conference (Virtual) TranscriptMar 16, 2022
- Q4 2021 Iovance Biotherapeutics Inc Earnings Call TranscriptFeb 24, 2022$14.85 (+5.24%)Earnings
- Iovance Biotherapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2022
- Iovance Biotherapeutics Inc at JMP Group Hematology and Oncology Summit (Virtual) TranscriptDec 07, 2021
- Iovance Biotherapeutics Inc at Stifel Healthcare Conference (Virtual) TranscriptNov 17, 2021
- Iovance Biotherapeutics Inc at Cowen Immuno-Oncology Next Summit (Virtual) TranscriptNov 15, 2021
- Iovance Biotherapeutics Inc to Discuss SITC Clinical Data Updates TranscriptNov 13, 2021
- Q3 2021 Iovance Biotherapeutics Inc Earnings Call TranscriptNov 04, 2021$24.51 (-1.41%)Earnings
- Q2 2021 Iovance Biotherapeutics Inc Earnings Call TranscriptAug 05, 2021$23.93 (+4.96%)Earnings
- Iovance Biotherapeutics Inc to Discuss Clinical Data for LN-145 in Non-Small Cell Lung Cancer- Conference Call TranscriptJun 29, 2021
- Iovance Biotherapeutics Inc at JMP Securities Life Sciences Virtual Conference TranscriptJun 17, 2021
- Iovance Biotherapeutics Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 09, 2021
- Iovance Biotherapeutics Inc to Discuss Clinical Data for Lifileucel at ASCO TranscriptJun 06, 2021
- Iovance Biotherapeutics Inc at Jefferies Healthcare Conference (Virtual) TranscriptJun 01, 2021
- Q1 2021 Iovance Biotherapeutics Inc Earnings Call TranscriptMay 06, 2021$28.61 (-2.09%)Earnings
- Iovance Biotherapeutics Inc at Truist Securities Life Sciences Summit (May Series) TranscriptMay 05, 2021
- Iovance Biotherapeutics Inc at Oppenheimer Healthcare Conference (Virtual) TranscriptMar 17, 2021
- Iovance Biotherapeutics Inc at Barclays Global Healthcare Conference (Virtual) TranscriptMar 11, 2021
- Iovance Biotherapeutics Inc at H C Wainwright Global Life Sciences Conference (Virtual)- Panel TranscriptMar 09, 2021
- Iovance Biotherapeutics Inc at H C Wainwright Global Life Sciences Conference (Virtual) TranscriptMar 09, 2021
- Q4 2020 Iovance Biotherapeutics Inc Earnings Call TranscriptFeb 25, 2021$36.51 (-7.38%)Earnings
- Iovance Biotherapeutics Inc at Guggenheim Partners Healthcare Talks Oncology Days TranscriptFeb 11, 2021
- Iovance Biotherapeutics Inc at B. Riley Oncology Investor Conference (Virtual) TranscriptJan 20, 2021
- Iovance Biotherapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 14, 2021
- Iovance Biotherapeutics Inc at Piper Sandler Healthcare Conference (Virtual)- Pre-recorded Fireside Chat TranscriptNov 20, 2020
- Iovance Biotherapeutics Inc at Jefferies Virtual London Healthcare Conference TranscriptNov 19, 2020
- Iovance Biotherapeutics Inc at Stifel Virtual Healthcare Conference TranscriptNov 18, 2020
- Iovance Biotherapeutics Inc at Credit Suisse Healthcare Conference (Virtual) TranscriptNov 09, 2020
- Q3 2020 Iovance Biotherapeutics Inc Earnings Call TranscriptNov 05, 2020$40.42 (+2.12%)Earnings
- Iovance Biotherapeutics Inc at Jefferies Cell Therapy Summit TranscriptOct 06, 2020
- Iovance Biotherapeutics Inc Provides Update for Lifileucel in Metastatic Melanoma- Corporate Call TranscriptOct 05, 2020
- Iovance Biotherapeutics Inc at BTIG Virtual Biotechnology Conference TranscriptAug 11, 2020
- Q2 2020 Iovance Biotherapeutics Inc Earnings Call TranscriptAug 06, 2020$31.15 (+0.94%)Earnings
- Iovance Biotherapeutics Inc at JMP Securities Hematology and Oncology Forum (Virtual) TranscriptJun 18, 2020
- Iovance Biotherapeutics Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 11, 2020
- Iovance Biotherapeutics Inc Annual Shareholders Meeting TranscriptJun 08, 2020
- Iovance Biotherapeutics Inc at Jefferies Healthcare Conference (Virtual) TranscriptJun 03, 2020
- Q1 2020 Iovance Biotherapeutics Inc Earnings Call TranscriptMay 05, 2020$32.66 (+1.27%)Earnings
- Q4 2019 Iovance Biotherapeutics Inc Earnings Call TranscriptFeb 25, 2020$31.46 (+27.42%)Earnings
- Iovance Biotherapeutics Inc at Credit Suisse Healthcare Conference - Scottsdale TranscriptNov 12, 2019
- Q3 2019 Iovance Biotherapeutics Inc Earnings Call TranscriptNov 04, 2019$20.46 (-6.87%)Earnings
- Q2 2019 Iovance Biotherapeutics Inc Earnings Call TranscriptAug 01, 2019$25.17 (+2.36%)Earnings
- Iovance Biotherapeutics Inc ASCO Abstracts Conference Call TranscriptMay 16, 2019
- Q1 2019 Iovance Biotherapeutics Inc Earnings Call TranscriptMay 07, 2019$11.01 (-3.93%)Earnings
- Q4 2018 Iovance Biotherapeutics Inc Earnings Call TranscriptFeb 27, 2019$10.65 (+1.91%)Earnings
Iovance Biotherapeutics Inc to Discuss the Pooled Analysis of Cohorts 2 and 4 of the C-144-01 Study Transcript
All right. I [would] ask if this thing is on, but obviously, it is. Good evening, everyone. My name is Friedrich Finckenstein, and I'm the Chief Medical Officer of Iovance. So welcome to our in-person and virtual event to review the clinical data highlights for our lead TIL therapy, lifileucel, in advanced melanoma. The results, as I'm sure you're aware, were presented earlier today by our lead investigator, Dr. Amod Sarnaik of the Moffitt Cancer Center, during a rapid oral presentation at the SITC meeting.
The presentation includes efficacy results in 153 patients. across 2 consecutively enrolled cohorts on study C-144-01. These results are the basis for our ongoing biologics license application, or BLA, submission for lifileucel, which we are very excited about. The Iovance leadership team is grateful to be joined by Dr. Sarnaik and a panel of key opinion leaders within the field to hear their perspectives on the data.
This is the agenda for today's call. Let's see -- that works too. That's good. First,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)